MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
217 hedge funds and large institutions have $5.02B invested in Mirati Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 58 increasing their positions, 69 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
15% less call options, than puts
Call options by funds: $87.7M | Put options by funds: $103M
16% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 69
Holders
217
Holding in Top 10
18
Calls
$87.7M
Puts
$103M
Top Buyers
| 1 | +$580M | |
| 2 | +$184M | |
| 3 | +$159M | |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$111M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$96.9M |
Top Sellers
| 1 | -$145M | |
| 2 | -$141M | |
| 3 | -$137M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$105M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$89.5M |